CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-04 | Payson Norman Director | Sale | −2,018 | $30.20 | $61K | 409,394 |
| 2022-08-04 | Payson Norman Director | Sale | −3,800 | $30.87 | $117K | 405,594 |
| 2022-08-04 | Payson Norman Director | Sale | −800 | $31.88 | $26K | 404,794 |
| 2022-08-03 | Payson Norman Director | Sale | −1,785 | $31.82 | $57K | 416,245 |
| 2022-08-03 | Payson Norman Director | Sale | −4,833 | $32.44 | $157K | 411,412 |
| 2022-07-25 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −226 | $31.82 | $7K | 87,305 |
| 2022-07-21 | Payson Norman Director | Sale | −6,618 | $33.28 | $220K | 418,030 |
| 2022-07-20 | Payson Norman Director | Sale | −6,618 | $33.40 | $221K | 424,648 |
| 2022-07-07 | Payson Norman Director | Sale | −3,400 | $30.39 | $103K | 434,484 |
| 2022-07-07 | Payson Norman Director | Sale | −3,218 | $31.32 | $101K | 431,266 |
| 2022-07-06 | Payson Norman Director | Sale | −5,220 | $29.26 | $153K | 439,282 |
| 2022-07-06 | Payson Norman Director | Sale | −1,398 | $29.81 | $42K | 437,884 |
| 2022-06-27 | Schlanger David J Executive Chairman | Exercise or conversion | +1,452 | $0.91 | $1K | 85,452 |
| 2022-06-27 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −1,452 | 1,732,228 | ||
| 2022-06-27 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +80 | $3.95 | $316 | 324,996 |
| 2022-06-27 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −80 | $31.21 | $2K | 324,916 |
| 2022-06-27 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −20 | $31.21 | $624 | 162,126 |
| 2022-06-27 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option | −80 | 1,675,556 | ||
| 2022-06-27 | Schlanger David J EXECUTIVE CHAIRMAN | Sale | −1,452 | $31.21 | $45K | 82,548 |
| 2022-06-23 | Payson Norman Director | Sale | −1,600 | $27.84 | $45K | 449,520 |
Page 49 of 77 · 1,524 trades